Media

Spruce Biosciences Further Strengthens its Commercial Leadership Team with the Appointments of Brian Walls as Vice President, Market Access and Darren Johnson as Vice President, Commercial Operations

Hemab Therapeutics Announces Pricing of Upsized Initial Public Offering

Vicore Pharma Announces Presentations at the 2026 American Thoracic Society International Conference

Oncopeptides publishes the 2025 Annual Report

Intervacc brings together leading US and European experts to jointly tackle strangles

Vicore Pharma Completes Enrollment in the Phase 2b ASPIRE Trial of Buloxibutid in Idiopathic Pulmonary Fibrosis

Aprea Therapeutics to Provide Clinical Update on ACESOT-1051 Phase 1 Trial Evaluating WEE1 Inhibitor, APR-1051, at ASCO 2026 Annual Meeting

Adcendo ApS Provides Updates on Pipeline Progress and Recent Achievements for Its First- and Best-in-Class Antibody-Drug Conjugates

Spruce Biosciences Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

Intervacc – Unprecedented decision opens the way for the launch of Strangvac in Iceland